Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment
نویسندگان
چکیده
منابع مشابه
P24: Neural Stem/Progenitor Cells Treatment for Spinal Cord Injury
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملCase Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury
Introduction: Various neuroregenerative procedures have been recently employed along with neurorehabilitation programs to promote neurological function after Spinal Cord Injury (SCI), and recently most of them have focused on the acute stage of spinal cord injury. In this report, we present a case of acute SCI treated with neuroprotective treatments in conjunction with conventional reha...
متن کاملCell Therapy in Spinal Cord Injury: a Mini- Reivew
Spinal cord injury (SCI) is a debilitating disease which leads to progressive functional damages. Because of limited axonal regeneration in the central nervous system, there is no or little recovery expected in the patients. Different cellular and molecular approaches were investigated in SCI animal models. Cellular transplantation of stem cells can potentially replace damaged tissue and provid...
متن کاملP6: Perspective of Stem Cell Therapy for Treatment of Spinal Cord Injury
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملStem cells therapy as a treatment for spinal cord injury
Spinal cord injury results in severe damage to motor, sensory and autonomic nervous functions and may leads to paraplegia and tetraplegia. Due to cellular loss, regeneration after spinal cord injury is limited1 and current approaches to treat spinal cord injury do not lead to complete cure. Embryonic stem cells transplantation (embryonic central nervous system or human umbilical cord blood stem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Molecular Sciences
سال: 2021
ISSN: 1422-0067
DOI: 10.3390/ijms22115966